BioLife Solutions

BioLife Solutions

BLFSPre-clinical
Bothell, United StatesFounded 1987biolifesolutions.com

BioLife Solutions is a science-driven company whose mission is to protect the integrity of cells to enable the development and delivery of advanced cell and gene therapies. The company offers a comprehensive portfolio of biopreservation media, cell processing and handling tools, and cell culture supplements, all aimed at improving process efficiency and ensuring regulatory compliance. With its products integrated into numerous customer clinical applications, BioLife is strategically positioned as a key supplier in the rapidly growing CGT market, supporting customers from early research to commercial scale.

Market Cap
$182.6M
Founded
1987
Focus
Cell TherapyGene TherapyRegenerative Medicine

BLFS · Stock Price

USD 3.7811.53 (-75.31%)

Historical price data

AI Company Overview

BioLife Solutions is a science-driven company whose mission is to protect the integrity of cells to enable the development and delivery of advanced cell and gene therapies. The company offers a comprehensive portfolio of biopreservation media, cell processing and handling tools, and cell culture supplements, all aimed at improving process efficiency and ensuring regulatory compliance. With its products integrated into numerous customer clinical applications, BioLife is strategically positioned as a key supplier in the rapidly growing CGT market, supporting customers from early research to commercial scale.

Technology Platform

Integrated platform of biopreservation media, cell culture supplements, and closed-system processing tools designed to maintain cell viability and integrity throughout the cell and gene therapy manufacturing workflow.

Funding History

4

Total raised: $64.7M

PIPE$50MUndisclosedSep 30, 2020
IPO$8.5MUndisclosedDec 15, 2005
Series A$5MUndisclosedJun 15, 2002
Seed$1.2MUndisclosedJun 15, 1999

Opportunities

Growth is driven by the rapid expansion of the cell and gene therapy pipeline, requiring scalable, GMP-compatible bioprocessing tools.
Opportunities include expanding its integrated product portfolio, deepening penetration into commercial-stage manufacturing, and forming strategic partnerships with leading CGT developers.

Risk Factors

Key risks include customer concentration, potential process changes by therapy developers or regulators, intense competition from larger life science tool companies, and dependency on the overall funding and clinical success rate of the CGT sector.

Competitive Landscape

Competes with large diversified players (Thermo Fisher, MilliporeSigma) and niche specialists in biopreservation media and platelet lysates. BioLife differentiates through its dedicated CGT focus, regulatory support services, and integrated suite of solutions designed specifically for cell therapy workflows.

Publications
8
Patents
16

Company Info

TypePlatform
Founded1987
LocationBothell, United States
StagePre-clinical
RevenueRevenue Generating

Trading

TickerBLFS
ExchangeNASDAQ

Therapeutic Areas

OncologyRegenerative MedicineRare Diseases
SIMILAR COMPANIES
BASi Research Products
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
EydisBio
Pre-clinical · Cambridge
3Spine
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile